References:
1. Lanzillotta M,Mancuso G,Della-Torre E. Advances in the diagnosis and management of IgG4 related disease [J].BMJ (Clinical research ed.), 2020, 369: m1067.
2. Löhr J M,Vujasinovic M,Rosendahl J, et al. IgG4-related diseases of the digestive tract [J].Nature reviews. Gastroenterology & hepatology, 2022, 19(3): 185-197.
3. Yu W,Freeland D M H,Nadeau K C. Food allergy: immune mechanisms, diagnosis and immunotherapy [J].Nature reviews. Immunology, 2016, 16(12): 751-765.
4. Majumder S,Mohapatra S,Lennon R J, et al. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease [J].Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018, 16(12): 1947-1953.
5. Aringer M,Costenbader K,Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus [J].Annals of the rheumatic diseases, 2019, 78(9): 1151-1159.
6. Umehara H,Okazaki K,Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 [J].Modern rheumatology, 2012, 22(1): 21-30.
7. Khan S,Zhu L P,Jiang K, et al. Immunoglobulin G4-Related Disease Manifesting as Isolated, Typical, and Nontypical Gastroesophageal Lesion: A Research of Literature Review [J].Digestion, 2020, 101(5): 506-521.
8. Notohara K,Kamisawa T,Uchida K, et al. Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey [J].Journal of gastroenterology, 2018, 53(7): 845-853.